These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 15237482

  • 1. [Etiology of nocturia and clinical efficacy of naftopidil on nocturia in patients with benign prostatic hyperplasia--analysis of frequency volume charts].
    Masuda M, Nakayama K, Hiromoto Y, Hirokawa M, Satomi Y, Shiramizu M, Furuhata A, Ikeda A, Kawasaki C.
    Hinyokika Kiyo; 2004 May; 50(5):309-14. PubMed ID: 15237482
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [The effectiveness of naftopidil in patients with benign prostatic hyperplasia evaluated by QOL index].
    Nakatsu H, Naoi M, Sekiyama K, Hamano S, Suzuki N, Tanaka M, Murakami S.
    Hinyokika Kiyo; 2007 Jan; 53(1):13-8. PubMed ID: 17310763
    [Abstract] [Full Text] [Related]

  • 5. Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.
    Nishino Y, Masue T, Miwa K, Takahashi Y, Ishihara S, Deguchi T.
    BJU Int; 2006 Apr; 97(4):747-51, discussion 751. PubMed ID: 16536766
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Long-term efficacy of naftopidil for treatment of lower urinary tract symptoms with benign prostatic hyperplasia].
    Akasaka T, Funaki H, Hirano S, Ohinata M, Fujishima M, Kudou T, Suzuki A, Iinuma M.
    Hinyokika Kiyo; 2003 Apr; 49(4):189-93. PubMed ID: 12784711
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of 25 and 75 mg/day naftopidil for lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective, randomized controlled study.
    Yokoyama T, Kumon H, Nasu Y, Takamoto H, Watanabe T.
    Int J Urol; 2006 Jul; 13(7):932-8. PubMed ID: 16882058
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Usefulness of naftopidil for dysuria in benign prostatic hyperplasia and its optimal dose--comparison between 75 and 50 mg.
    Oh-oka H.
    Urol Int; 2009 Jul; 82(2):136-42. PubMed ID: 19321997
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Additional effect of propiverine for naftopidil-resistant nocturia in the patient with benign prostate hypertrophy].
    Kamimura N, Hatakeyama S, Kudo S, Yoneyama T, Hashimoto Y, Koie T, Yoshikawa K, Kawaguchi T, Takahashi S, Ohyama C.
    Hinyokika Kiyo; 2011 Feb; 57(2):71-6. PubMed ID: 21412038
    [Abstract] [Full Text] [Related]

  • 15. Naftopidil monotherapy vs naftopidil and an anticholinergic agent combined therapy for storage symptoms associated with benign prostatic hyperplasia: A prospective randomized controlled study.
    Maruyama O, Kawachi Y, Hanazawa K, Koizumi K, Yamashita R, Sugimura S, Honda S, Sugiyama Y, Saitoh T, Noto K.
    Int J Urol; 2006 Oct; 13(10):1280-5. PubMed ID: 17010005
    [Abstract] [Full Text] [Related]

  • 16. A prospective, randomized, controlled, multicenter study of naftopidil for treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia: 75 mg once daily in the evening compared to 25 mg thrice daily.
    Tsuritani S, Nozaki T, Okumura A, Kimura H, Kazama T.
    Urol Int; 2010 Oct; 85(1):80-7. PubMed ID: 20516676
    [Abstract] [Full Text] [Related]

  • 17. Clinical observations of the effect of antidiuretic hormone on nocturia in elderly men.
    Ho DR, Lin WY, Wu CF, Shee JJ, Huang YC, Chen CS.
    BJU Int; 2005 Dec; 96(9):1310-3. PubMed ID: 16287451
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial.
    Johnson TM, Jones K, Williford WO, Kutner MH, Issa MM, Lepor H.
    J Urol; 2003 Jul; 170(1):145-8. PubMed ID: 12796667
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.